GYNECARE INTERCEED 5INX6IN 4350XL

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-26 for GYNECARE INTERCEED 5INX6IN 4350XL manufactured by Ethicon Inc..

Event Text Entries

[186813534] (b)(4). To date the device has not been returned. If the device or further details are received at the later date a supplemental medwatch will be sent. Additional information was requested, and the following was obtained: were pre-existing adhesion noted during the procedure? No further information is available. How were post-procedural adhesions confirmed? Location and severity? During a reoperation, it was observed that adhesion had occurred at the area where the interceed had been applied. (just under the abdominal wall. ) how were adhesions treated? No further information is available. What was a reason for reoperation on (b)(6) 2019? No further information is available. What is physician? S opinion as to the etiology of or contributing factors to this event? The surgeon commented that there is no particular difference from the general case. The only difference is that reoperation was performed in a short period of 2 weeks. The patient is slender figure. Celecox (cough medicine) was used postoperatively. What is the patient's current status? The patient has been discharged from the hospital. Product lot number? The lot number is unknown. We will update the note, if we get the additional information.
Patient Sequence No: 1, Text Type: N, H10


[186813535] It was reported that the patient underwent an open rectal cancer surgery and peritoneal dissemination surgery on (b)(6) 2019 and the absorbable adhesive barrier was applied under the abdominal wall. On (b)(6) 2019, during a reoperation, it was observed that adhesion had occurred at the area where the absorbable adhesive barrier had been applied. The condition of the adhesion was sticky and hard. The surgeon opined that there is no particular difference from the general case. The only difference is that reoperation was performed in a short period of 2 weeks. The patient is slender figure and celecox/cough medicine was used postoperatively. The patient has been discharged from the hospital.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2020-02410
MDR Report Key9887182
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-26
Date of Report2020-03-04
Date of Event2019-12-09
Date Mfgr Received2020-03-04
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.-SAN LORENZO PR
Manufacturer Street982 ROAD 183 KM 8.3
Manufacturer CitySAN LORENZO PR
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGYNECARE INTERCEED 5INX6IN
Generic NameBARRIER, ABSORBABLE, ADHESION
Product CodeMCN
Date Received2020-03-26
Model Number4350XL
Catalog Number4350XL
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 08876 US 08876


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.